Form 4 Tracker
Paul A Mahon

EVP & GENERAL COUNSEL · 12 filings · Latest: Jun 18, 2026

UNITED THERAPEUTICS Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
UTHR
PAUL MAHONMar 19, 2026
Proposed Sale
$529.958,300$4.4M
UTHR
Paul A MahonEVP & GENERAL COUNSELMar 15, 2026
Option Exercise
16,69153,535
UTHR
Paul A MahonEVP & GENERAL COUNSELMar 5, 2026
Sale
$483.168,300$4.0M36,844
UTHR
Paul A MahonEVP & GENERAL COUNSELMar 5, 2026
Option Exercise
$146.038,300$1.2M45,144
UTHR
PAUL MAHONMar 5, 2026
Proposed Sale
$483.168,300$4.0M
UTHR
Paul A MahonEVP & GENERAL COUNSELFeb 19, 2026
Sale
$476.348,300$4.0M36,781
UTHR
Paul A MahonEVP & GENERAL COUNSELFeb 19, 2026
Option Exercise
$146.038,300$1.2M45,081
UTHR
PAUL MAHONFeb 19, 2026
Proposed Sale
$476.348,300$4.0M
UTHR
Paul A MahonEVP & GENERAL COUNSELFeb 5, 2026
Sale
$483.258,300$4.0M36,781
UTHR
Paul A MahonEVP & GENERAL COUNSELFeb 5, 2026
Option Exercise
$146.038,300$1.2M45,081
UTHR
PAUL MAHONFeb 5, 2026
Proposed Sale
$483.258,300$4.0M
UTHR
PAUL MAHONJan 15, 2026
Proposed Sale
$469.898,300$3.9M
UTHR
PAUL MAHONJan 2, 2026
Proposed Sale
$485.438,300$4.0M
UTHR
PAUL MAHONDec 24, 2025
Proposed Sale
$513.1811,000$5.6M
UTHR
PAUL MAHONDec 11, 2025
Proposed Sale
$484.6711,000$5.3M
UTHR
PAUL MAHONNov 26, 2025
Proposed Sale
$486.0611,000$5.3M
UTHR
PAUL MAHONNov 13, 2025
Proposed Sale
$464.7611,000$5.1M
UTHR
PAUL MAHONOct 30, 2025
Proposed Sale
$450.3411,000$5.0M
UTHR
PAUL MAHONOct 16, 2025
Proposed Sale
$431.5011,000$4.7M
UTHR
PAUL MAHONOct 2, 2025
Proposed Sale
$436.6011,000$4.8M